Evidence map›Paper›PMID 42412058›Full record

ArticlePsycho-oncology2026

Introducing the Ottawa Clinical Fear of Recurrence-Self-Report; A New Assessment Tool for Clinical Fear of Cancer Recurrence.

Lauriane Giguère, Emma Kearns, Suchithra Shenthil, Brittany Mutsaers, Cheryl Harris, Allan 'Ben' Smith, Gerald M Humphris, Daniel Costa, Cary S Kogan, Sébastien Simard and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Psycho-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lauriane GiguèreSchool of Psychology, University of Ottawa, Ottawa, ON, Canada.ORCID https://orcid.org/0000-0002-6992-3132
Emma KearnsSchool of Psychology, University of Ottawa, Ottawa, ON, Canada.ORCID https://orcid.org/0009-0009-3577-0949
Suchithra ShenthilSchool of Psychology, University of Ottawa, Ottawa, ON, Canada.
Brittany MutsaersSchool of Psychology, University of Ottawa, Ottawa, ON, Canada.ORCID https://orcid.org/0000-0001-8343-1938
Cheryl HarrisSchool of Psychology, University of Ottawa, Ottawa, ON, Canada.
Allan 'Ben' SmithThe Daffodil Centre, The University of Sydney, a Joint Venture with Cancer Council NSW, Ottawa, ON, Canada.
Gerald M HumphrisSchool of Medicine, University of St Andrews, St Andrews, UK.
Daniel CostaSchool of Psychology, The University of Sydney, Sydney, Australia.
Cary S KoganSchool of Psychology, University of Ottawa, Ottawa, ON, Canada.
Sébastien SimardDepartment of Health Sciences, Université du Québec à Chicoutimi (UQAC), Saguenay, QC, Canada.
Sophie LebelSchool of Psychology, University of Ottawa, Ottawa, ON, Canada.
FORWARDS

Funding

Fonds de recherche du Québec en santéOntario Graduate ScholarshipUniversity of Ottawa's Faculty of Social Scien
6 · The paper itself

Abstract

backgroundThe Ottawa Clinical Fear of Recurrence-Self-Report (OCFR-SR) was developed to enable brief assessment of clinically significant fear of cancer recurrence (FCR) according to recently updated criteria based on expert consensus: a) high levels of worry, b) high levels of preoccupation, c) hypervigilance of bodily symptoms, and d) that last for more than 3 months.

aimThe study evaluated the OCFR-SR item pool with the goal of optimizing its brevity and psychometric properties.

methodsThe OCFR-SR's 23 candidate items were administered to mixed cancer survivors recruited from The Ottawa Hospital along with other assessment measures within the questionnaire package. Eligible participants had to have been diagnosed with any cancer, stages I-III, and have completed primary treatment. Exploratory factor analysis, item response theory, and internal reliability were used to optimize the number of items. Internal (MacDonald's omega and Cronbach's alpha) and test-retest reliability (intra-class correlation) were assessed. Finally, convergent and discriminant validity were explored (Pearson correlations and z-tests).

resultsA total of N = 296 survivors completed the questionnaire package. Seven items were selected for the final version of the OCFR-SR. All items performed similarly on psychometric assessments. Theoretical considerations were decisive in selecting the final items. The final OCFR-SR demonstrated satisfactory convergent and discriminant validity, and internal and test-retest reliability.

conclusionsThis study introduces the final seven-item OCFR-SR, enabling clinicians and researchers to assess the clinical significance of FCR according to the recently updated criteria. It is the first brief self-report tool aimed at assessing clinical FCR.

Indexed as

Cancer SurvivorsFearNeoplasm Recurrence, LocalNeoplasmsSelf ReportAdultAgedAnxietyFactor Analysis, StatisticalFemaleHumansMaleMiddle AgedPsychometricsReproducibility of ResultsSurveys and Questionnairescancerfear of cancer recurrenceitem response theoryoncologypatient‐reported outcome measurespsycho‐oncology

Identifiers

PMID42412058
PMCPMC13340200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.